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ABSTRACT 
Cultured  normal low-passage embryo fibroblasts,  from a  number of species,  and 
two  untransformed  clones  of a  Balb/3T3  line  elaborate  increasing  amounts  of 
plasminogen  activator  (PA)  as  they  approach  confluence;  the  low-passage  cells 
then lose this  PA activity after reaching confluence, while  the  3T3 cells retain  it 
indefinitely.  Even  at  their  peaks,  however,  the  PA activities  of the  low-passage 
cells  remain  well  below  those  of  the  corresponding  virally  or  spontaneously 
transformed  cells.  The PA increases  in normal cells are  probably a  result of PA 
production  rather  than  of adsorption  of secreted  PA  to  the  cell  surface,  or  of 
changes in  cell-associated  protease  inhibitors.  The elaboration  of PA by normal 
cells  is  dependent  upon  their  metabolic  activity,  such  that  the  level  of serum 
supplementation  and the growth phase of the culture directly influence the level of 
cell-associated  PA  observed.  In  addition,  there  may be  a  component  of serum 
which exerts a  negative control on PA production and which is not an acid-labile 
protease  inhibitor. 
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The  production  of a  high  level  of plasminogen 
activator (PA) in culture has recently come to be 
recognized as a distinctive property of many trans- 
formed cells.  Production of this enzyme has been 
associated  with viral,  chemical,  and spontaneous 
transformation in a number of avian and mamma- 
lian  species  (8,  16-19,  22,  31,  33),  and  with 
specific properties of the transformed phenotype, 
including rounded cell  morphology (16,  18),  mi- 
gration into a wound (16, 17), growth in soft agar 
or methocel  (16,  18,  19),  and  tumorigenicity in 
nude mice (19). 
Some normal cells  are also capable of produc- 
ing this enzyme, however. Activated macrophages 
and  cells  from  the  lung,  heart,  and  kidney  are 
generally good sources of PA (1, 3, 4, 32). Other 
cells produce PA only at specific, restricted times. 
For instance, before ovulation and during embryo 
implantation in the mouse the amount of PA syn- 
thesized by follicle  cells  and trophoblast cells, re- 
spectively, rises  dramatically and later falls  again 
in an apparently regulated manner (2, 28, 29). 
Clearly,  any assessment  of the  significance of 
PA  in  bringing  about  or  maintaining  the  trans- 
formed phenotype must be made in the context of 
the function and regulation of PA in normal cells. 
In this study, we have analyzed the patterns of PA 
production in cultures of normal low-passage em- 
bryonic  cells  and  of two  clones  of an  untrans- 
formed  mouse  cell  line.  Reported  here  are  our 
observations  on  the  variations  in  PA  level  that 
result  from  differences  in  the  seeding  density, 
growth  rate,  and  serum  supplementation  of un- 
transformed cells. 
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Cells 
Primary  embryo  fibroblast  cultures  were  prepared 
from  13-day-old  C57B1/6  mouse  embryos  (pregnant 
mice from Jackson Laboratories, Bar Harbor, Maine). 
Whole  embryos  were  minced  extensively,  washed  in 
0.14  M  NaCI,  0.005  M  KC1,  0.024  M  Tris-HC1,  and 
0.0004  M  Na~HPO4,  pH  7.4  (TD)  and  subjected  to 
three successive 20-rain trypsinizations in 0.25% trypsin. 
Cells  released  by the  trypsin  were  then suspended  in 
Dulbecco's modified Eagle's medium supplemented with 
10% fetal bovine serum (FCS) and plated at 10  ~  cells per 
100-mm plate (Falcon Plastics, Div. of BioQuest, Ox- 
nard, Calif.).  Confluent primary cultures were trypsin- 
ized and either stored in liquid nitrogen or passed to new 
plates for direct use in experiments. 
Secondary or tertiary C57B1/6 mouse embryo fibro- 
blasts were used for most of the experiments. Cells were 
seeded on 100-mm plates at a density of 5 ￿  10  s cells per 
dish. Each day for 10 or more days, the cells on one plate 
were trypsinized and counted to monitor cell growth, and 
the cells on companion plates were scraped for PA deter- 
minations. The medium in the remaining plates of cells 
was changed daily, except where otherwise noted. 
Plates  of  cells  for  vital  staining  experiments  were 
washed with TD and stained at room temperature for 10 
rain with 0.4% trypan blue in 0.137 M NaCl, 3 mM KC1, 
8 mM Na~HPO,,  1 mM KH2PO4,  1 mM CaC12, 1 mM 
MgCl2,  pH  7.4  (PBS).  The dye  solution was  then re- 
moved by aspiration, the plates were washed twice with 
TD and the cells trypsinized with 2 ml of 0.25% trypsin 
at 37~  After 5 min, 2 ml of medium with 10% FCS 
were added to the plate, and the cells were suspended 
thoroughly  and  counted  in  a  hemocytometer.  Both 
stained (blue) and total cell counts were recorded. 
In addition to inbred C57B1/6 mouse embryos, em- 
bryos  from  Balb/c mice  (Jackson  Laboratories),  wild 
mice  (collected  in  Bouquet  Canyon,  Calif.,  and  fur- 
nished through the kindness of M. B. Gardner and V. 
Klement,  University of Southern California School of 
Medicine, Los Angeles, Calif.), rats ("Fisher" rats from 
Charles River Breeding Laboratories, Inc., Wilmington, 
Mass.),  hamsters (Lakeview Golden  Hamster  Colony, 
Newfield,  N.  J.),  chickens  (Spafas  Inc.,  Norwich, 
Conn.), and humans (from therapeutic abortions) were 
also  used  as  sources  of secondary  or  tertiary  embryo 
fibroblasts. Primaries were prepared from these embryos 
at 11 days (chicken), 13 days (mouse, rat, and hamster), 
or 6-8 wk (human) of gestation, using the method de- 
scribed above for C57B1/6. Two A31 clones of the Balb/ 
3T3 line, one a gift from E. Scolnick (National Institutes 
of Health, Bethesda, Md.) and the other a gift from R. 
Pollack (State University of New York at Stony Brook, 
N. Y.), a human melanoma, RPM1 No. M7272, and a 
liposarcoma,  RPM1  No.  1922,  both from  G.  Moore 
(Denver General Hospital, Denver, Colo.), and normal 
human embryonic lung and skin cells from Flow Labora- 
tories (Rockville, Md.), were also used in some experi- 
ments. 
All cells were grown in Dulbecco's modified Eagle's 
medium  supplemented with  10%  FCS  except  for  the 
chicken cells, which were  cultured in Eagle's minimal 
medium supplemented with 10% FCS, and the human 
cells,  which  were  cultured  in  either  Eagle's  minimal 
medium or RPM1  1640 supplemented with 10% FCS. 
Cells were cultured in an atmosphere of 10% CO2-90% 
air at 37~ 
Cells  to  be  transformed  by  murine  sarcoma  virus 
(MSV)  were  pretreated  for  40  rain  with  25  #.g/ml 
DEAE-dextran (Pharmacia Fine Chemicals, Piscataway, 
N. J.) in TD, then infected with 1 ml of virus-containing 
medium per sparse  100-ram petri dish.  After 40  rain, 
medium was added and the cells were left at 37~  for 3 
days or until all the cells became morphologically trans- 
formed.  They  were  used  without  further  passaging. 
Transformed chicken cells were  prepared by infecting 
secondary cultures with Rous sarcoma virus (RSV), sub- 
group A,  using an isolate obtained from H.  Hanafusa 
(The Rockefeller University, New York). Hamster cells 
transformed with simian virus  40  (SV40)  were  a  gift 
from L. Ossowski (The Rockefeller University). 
Determination of Intracellular 
PA Levels 
Cells to be assayed for PA were washed twice with ice- 
cold TD, scraped off the plate with a Teflon or rubber 
policeman, and collected by centrifugation at 2,000 g for 
3  min. The supernate was then removed by aspiration 
and the cell pellet was spun in 0.5-1.0 ml of ice-cold 0.1 
M  Tris-HCl,  pH  8.1,  containing 0.5%  Triton  X-100. 
This extract was centrifuged for 10 rain at 500 g and the 
supernate retained for protein determination (12)  and 
PA assay. 
The radioactive assay of Unkeless et al. (33) was used 
to determine PA levels: 2.5, 5, 10, or 15  /~g of extract 
protein were  added to a  35-mm  petri dish, previously 
coated with 125I-fibrinogen (10/~g/cm  ~, 50,000 cpm) and 
activated for 3 h, together with 2 ml of 0.1 M Tris-HC1, 
pH 8.1,500  /~g of bovine serum albumin (BSA) and 4 
/~g of purified FCS  plasminogen  (6).  Purified chicken 
plasminogen, 14 g.g per dish, was used instead of FCS 
plasminogen  for  assays  of  chicken  cell  extracts.  The 
dishes were incubated at 37~  and the supernatant fluid 
was assayed for solubilized 125I-fibrin degradation prod- 
ucts in a gamma counter at 2 and 4 h. Sometimes, linbro 
dishes (Linbro, New  Haven, Conn.) were  used rather 
than  35-mm  dishes.  In  these  assays,  the  amounts  of 
sample protein were reduced to 0.5, 1, 2, and 3 v.g per 
well, the amounts of Tris buffer and BSA were reduced 
fourfold, and the amount of plasminogen was unchanged 
(4 gg of FCS plasminogen per well). The value for each 
time-point  is  the  average  of  two  determinations  per- 
formed on a given sample. Only values in the range of 
the assay linear with respect to both time and sample 
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was assayed at a number of protein concentrations and 
the  assay  was  monitored at  more  than  one  time.  In 
general, the range in which this assay is linear will vary 
according to the activity  of the sample, so that sample 
concentrations and  assay  time-points must  be  chosen 
carefully  in accordance with the desired sensitivity.  No 
plasminogen-independent  fibrinolysis  was  observed. 
Negative activities  were recorded for samples releasing 
fewer than  the  background number of counts  (buffer 
plus BSA and plasminogen). 
A relative unit (R.U.) of PA is defined as that activity 
which will solubilize  5%  of the radioactivity  in a  dish, 
after correction for background, in  1 h  at  37~  in the 
presence of 2 #,g of plasminogen and 1 ml of Tris-HC1 
buffer, pH 8.1.  Since the extent of fibrin cross-linking 
can vary among batches of assay plates, urokinase stan- 
dards were run  with each assay  to permit quantitative 
comparisons among assays. One Ploug unit of Urokinase 
Reference  Standard  (Leo  Pharmaceutical  Products, 
Bailerup,  Denmark)  was equated  to  30  R.U.  in  the 
presence of FCS  plasminogen, or  to  1.5  R.U.  when 
chicken plasminogen was used. The presence of BSA in 
the  assay  increased  the  urokinase  activity  3.33-fold. 
Although  the  PA  units  for  mammalian  and  chicken 
systems are both defined arbitrarily  here with respect to 
human  urokinase  activity,  these  two  units  are  not 
equivalent. Species-specificity plays a marked role in the 
efficiency  of plasminogen activation;  while  activation 
efficiencies  of  different  mammalian  plasminogens by 
human urokinase are similar, the activation efficiencies 
of bird and  mammalian plasminogens by  human  uro- 
kinase differ by an order of magnitude. One is therefore 
left with two distinct activations that cannot be compared 
directly:  the activation of bird plasminogen by bird PA 
and the activation  of mammalian plasminogen by mam- 
malian PA. 
Measurement of PA Secretion 
Cells whose PA secretion was to be measured were 
washed with TD and incubated in  10 ml of serum-free 
medium for 4 hr. The conditioned serum-free medium 
was collected, centrifuged for 10 min at 3,000 g, and 50 
/~1 of the supernatant fluid were assayed in a~I-fibrin- 
coated linbro wells as described above, with the medium 
substituted for cell extracts as the source of PA. 
Extracts of Transformed Cells 
and  Tumor Lines 
Transformed cells were extracted in the same way as 
the normal cells, with 0.5% Triton X-100 in 0.1 M Tris- 
HC1, pH  8.1.  Since  in some cases their cell-associated 
PA  levels were also found  to  vary  with cell  density, 
although not in  the  regular fashion reported here for 
normal cells  (S.  Rohrlich, unpublished results), we al- 
ways chose to scrape them at their peak of PA produc- 
tion, which generally corresponded to visual confluence 
of the culture. 
Overlay Assays for Fibrinolysis 
C57B1/6 cells seeded at 4  x  104 (sparse) or 2  ￿  106 
(confluent) cells  per  60-ram  plate  were washed twice 
with serum-free medium a day after plating, then over- 
laid in the presence or absence of 50/~g of FCS plasmin- 
ogen with a mixture of Eagle's minimal medium, purified 
agar, topical thrombin, and bovine fibrinogen, according 
to the method of Jones et al. (7). After incubation for 25 
h at 37~  the culture dishes were stained with 0.02% 
Coomassie Blue in a mixture of methanol:glacial acetic 
acid:water, 7:1:2  (vol:vol:vol),  and examined for areas 
of fibrinolysis. 
Trypsin and Plasmin 
Inhibitor Assays 
An adaptation of the PA assay was used to determine 
levels of inhibitors of proteases such as trypsin or plas- 
min. The sample to be assayed was preincubated for 30 
min at room temperature with 1 ml of 0.1  M Tris-HCl, 
pH 8.1, containing 0.25  /~g of trypsin and 0.25  /xg of 
BSA, then  500  /zl of the mixture were transferred to 
each  of two  linbro  wells  containing  mI-fibrin  as  de- 
scribed for the PA assay.  The assay  was incubated at 
37~  for 1 h, and 250  p,l of the supernatant fluid were 
withdrawn for determination of counts, as  in  the  PA 
assay.  Again, a range of concentrations of sample was 
assayed, and the percent of inhibition was calculated  by 
subtracting the per cent of solubilized radioactivity, after 
correction for background, from the total solubilizable 
counts in the well, or 100 per cent. Some, but not all, of 
the samples were also tested for plasmin inhibition by the 
substitution  of plasmin for  trypsin  in  this  assay.  The 
plasmin was generated from plasminogen by preincubat- 
ing 25  Ploug units of urokinase with each 1 p,g of FCS 
plasminogen for  30  min  at  37~  in  activation  buffer 
(25% glycerol  in 0.04 M Tris-HC1,  pH 9.0, containing 
0.01  M lysine and 0.08 M NaCI). The equivalent of 0.25 
p,g  of  plasminogen was  used  for  each  sample  to  be 
assayed. Assay time-points were taken at 1 and 2 h. 
Acid Treatment to Destroy 
Acid-Labile  Inhibitors 
Cell extracts and FCS were acid-treated in some ex- 
periments to remove acid-labile inhibitors of fibrinolysis. 
Samples were brought to pH 2 by adding 1 N HC1, held 
at room temperature for 21/2 h, then reneutralized with 1 
N NaOH. 
Perchloric Acid Extraction of 
Acid-Stable Protease Inhibitors 
Cell extracts, made as described earlier, were dialyzed 
against two changes of 10 mM sodium acetate, pH 5.0 at 
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vol of concentrated perchloric acid (70-72%), and the 
mixture was centrifuged at 12,000 g for 10 rain at 4~ 
The supernate was collected and again dialyzed against 
two changes of 10 mM sodium acetate,  pH 5.0,  then 
assayed for protein and for acid-stable inhibitors in the 
trypsin and plasmin inhibitor assays described above. 
Drug Experiments 
Concentrated stock solutions of drugs were diluted in 
serum-free medium to the following  final concentrations: 
10 gg/ml cytosine arabinoside, 4/~g/ml actinomycin D, 
5 g.g/ml cycloheximide, 10 ~g/ml colchicine, 7.6/~g/ml 
dibucaine hydrochloride, and  1 mM NaN  a +  10  mM 
NaF. 10 ml of one of these drug-supplemented media or 
a nondrug control medium were added to each plate of 
TD-washed cells and left on the cells for the duration of 
the experiment. Sample plates of cells were washed and 
scraped  at  2,  4,  and  24  h  of  incubation,  and  were 
extracted and assayed as described above. 
Reagents 
Cytosine arabinoside, cycloheximide, and colchicine 
were purchased from Sigma Chemical Co.  (St. Louis, 
Mo.) and  dibucaine hydrochloride from the  Amend 
Drug and Chemical Co., Inc. (New York). Actinomycin 
was a gift from Merck Sharp and Dohme (Rahway, N. 
J.).  Crude fibrinogen, obtained from Pentex Biochemi- 
cal (Kankakee, I11.) was purified and freed of plasmino- 
gen by ammonium sulfate precipitation and two ethanol 
precipitations, according  to the methods of Laki (10) and 
Mosesson (14). Plasminogen was purified from chicken 
serum or from FCS by the method of Deutsch and Mertz 
(6). Crystalline  bovine albumin was purchased from Pen- 
tex Biochemical. 
Powdered media were purchased from Grand Island 
Biological Co. (Grand Island, N. Y.). They were supple- 
mented  with 60  /~g/ml tylosin (Associated Biomedic 
Systems, Buffalo, N. Y.), 200 p,g/ml streptomycin and 
500 U/ml penicillin (both from Pfizer Chemicals Div., 
New York). The Eagle's minimal medium was further 
supplemented with 4  ￿  glucose. Sera were purchased 
from Grand  Island  Biological Co.  and  from Reheis 
Chemical Co.  (Phoenix,  Ariz.),  Hanks'  saline  from 
Grand Island Biological  Co., and trypsin from ICN Phar- 
maceuticals Inc.,  Life Sciences Group-NBC  Division 
(Cleveland, Ohio). All other reagents were of the high- 
est commercial grade available. 
RESULTS 
Early Passage Embryonic Cells 
We have compared the cell-associated PA levels 
of normal embryonic cells from a number of spe- 
cies with their viral or spontaneous transformants. 
Figs.  1-5  show  representative  PA  profiles  as  a 
function of cell density from early passage embryo 
fibroblasts. All of the normal embryonic cells have 
barely  detectable  intracellular PA  levels at  low 
density.  All  but  the  chicken  and  hamster  cells 
develop increasingly higher PA levels as they ap- 
proach and attain confluence, and gradually lose 
some or all of the activity again after confluence. 
The peak level of PA varies greatly from species 
to  species.  Chicken  embryo  fibroblasts  (CEF) 
never develop any measurable PA activity (Fig. 1) 
although RSV-A-transformed CEF are relatively 
active (133 R.U./mg). This lack of detectable PA 
activity in normal CEF cells  maintained in  10% 
FCS also holds true when the cells are maintained 
in medium supplemented with 5, 1, or 0.1% FCS 
(data not shown). In the 0.1% serum supplement, 
the cells go through only one doubling in 19 days 
despite  daily changes of medium. Clearly, then, 
the  PA level in CEF cells does not change as a 
function of their growth rate. 
Normal  hamster  embryo  fibroblasts  (Fig.  2) 
have the lowest measurable activity, 41 R.U./mg, 
compared with 448 R.U./mg for an SV40 trans- 
formant of the same cells, and this low PA level 
remains fairly constant throughout  their  growth 
cycle.  At  the  opposite  end of the  spectrum are 
human  embryo  fibroblasts  (HEF),  which  start 
with  very low  PA activities at  low densities but 
develop  much  higher  PA  activities as  they  ap- 
proach confluence. Although the intracellular PA 
level of sparse HEF (Fig. 3) is only 6 R.U./mg, at 
confluence their PA activity rises to 142 R.U./mg 
and continues to rise for several days after the cells 
have become confluent, reaching 268 R.U./mg at 
its peak. Still, even this high level of PA activity is 
fourfold lower than the  PA activity of an active 
human melanoma line (1,100 R.U./mg); it is com- 
parable to  the  activity generated by a  relatively 
inactive human liposarcoma line (220 R.U./mg). 
Human embryonic skin (HES) and human em- 
bryonic lung (HEL) cultures are different from the 
HEF cultures obtained from whole embryos and 
may  represent  more  specialized,  homogeneous 
cell populations. HES cells show patterns of cell- 
associated  PA  activities  qualitatively similar  to 
those  seen for HEF cells, but HES cells have a 
much lower peak value, 20 R.U./mg. HEL cells 
have considerably more activity than HEF cells; 
their  PA  level,  1,065  R.U./mg,  remains fairly 
uniform  throughout  their  life  in  culture  and  is 
about equivalent to that of the human melanoma 
line (data not shown). 
The patterns of PA production for rat embryo 
fibroblasts (REF) and C57B1/6  (mouse) embryo 
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FIGURES 1-6  Cell-associated PA activity (I)  as a  function of cell density in cultures of normal low- 
passage  CEF (Fig.  1), hamster embryo fibroblasts  (Fig. 2), HEF (Fig. 3), REF (Fig. 4), C57B1/6 embryo 
fibroblasts  (Fig. 5), and the Scolnick A31 clone of Balb/3T3 (Fig. 6). Daily cell counts on 100-ram  dishes 
(O), visual confluence of the cells (arrows), and passaging  of the cells to new plates (double slash marks) 
are all indicated. On days of cell passaging,  the samples assayed for PA came from confluent plates before 
trypsinization. Also shown for comparison are the cell-associated PA levels of corresponding transformed 
cells or tumor-derived lines: RSV-A-transformed CEF (--), Fig.  1; SV40-transformed hamster embryo 
fibroblasts  (-.-),  Fig.  2;  a  human  melanoma  (-.-),  and  liposarcoma (--),  Fig. 3; MSV-transformed 
REF  (--),  Fig.  4;  MSV-transformed  C57Bi/6  embryo  fibroblasts  (--),  Fig.  5;  and  a  fresh  MSV 
transformant of the Scolnick Balb/3T3 clone (- -), Fig. 6. 
fibroblasts, which develop intermediate PA levels, 
are  shown  in  Figs.  4  and  5,  respectively, along 
with  their  MSV-transformed  counterparts.  Wild 
mouse  and  Balb/c  cells behave  identically with 
C57B1/6.  Furthermore, no differences in activity 
are observed between C57B1/6 cells derived from 
eviscerated embryos rather  than  whole  embryos, 
nor  in  cells  from  15-day  embryos  as  compared 
with cells from 13-day embryos (data not shown). 
In each of these examples, the normal fibroblasts 
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transformants. 
Balb /3 T3 
As shown  in  Fig. 6,  the  Balb 3T3  clone A31 
obtained from  Scolnick also  elaborates PA  in  a 
cell density-dependent manner.  As with low-pas- 
sage normal embryo fibroblasts, A31 cells go from 
no cell-associated PA when  they are sparse, to a 
peak level of 248  R.U./mg at confluence. There 
are two major differences, however, between the 
PA pattern of A31 cells, which are an established 
cell line, and that of low-passage mouse embryo 
fibroblasts. The  peak PA level of A31  is almost 
three times higher than the peak PA level of the 
low-passage mouse cells. Furthermore, it remains 
high  indefinitely beyond  confluence,  instead  of 
falling again. (The Balb/3T3 clone A31 from Pol- 
lack has qualitatively the same PA profile as that 
from  Scolnick,  but  the  peak  level  is  only  170 
R.U./mg.) In addition, the fresh MSV transform- 
ant  of the  Scolnick A31  clone  has a  lower cell- 
associated PA level, 107  R.U./mg, than  does its 
untransformed counterpart. This transformed PA 
level is close  to  the  level of PA  in  MSV-trans- 
formed  low-passage  mouse  embryo  fibroblasts, 
which is 148 R.U./mg. 
In summary,  it is clear that  the  PA profile of 
embryonic cells from a number of different species 
varies with  cell density and  growth rate,  though 
the  peak  level of cell-associated PA  activity, at 
least for early-passage embryonic ceils, always re- 
mains well below the  PA level of corresponding 
transformed cells. The  absolute value of the  PA 
activity at its peak differs considerably from spe- 
cies to species. 
Mouse Embryo Fibroblasts 
In  an  attempt  to  determine  the  factors  that 
might be responsible for the observed PA varia- 
tions, we examined low-passage C57B1/6 embryo 
fibroblasts in some detail. 
The  serum  supplement  with  which  C57B1/6 
cells are provided affects their growth rate and has 
a small quantitative effect on their cell-associated 
PA levels, although it has no qualitative effect on 
the pattern of PA elaboration with time. Thus, in 
10%  serum, which supports 41/2 cell doublings in 
10 days, the peak of cell-associated PA activity is 
91  R.U./mg (Fig. 5), whereas in 2% serum (2)/2 
doublings in 10 days) it is 68 R.U./mg, and in 1% 
serum  (1/2 doubling in  10 days) it is 61  R.U./mg 
(data not shown). If C57B1/6 cells are maintained 
in a  2%  serum supplement without any medium 
change in the course of a  10-day experiment (11/2 
doublings), the PA activity formed is still lower, 
reaching  a  peak  of only  30  R.U./mg  (data  not 
shown). 
Fig. 7 shows the overall PA pattern for C57B1/6 
cells maintained for four passages. In the course of 
each passage, the cell-associated PA level rises as 
the culture becomes confluent and falls again with 
each  trypsinization  and  sparse  replating.  These 
PA changes are observed with trypsinization and 
sparse replating of other cell types also, for exam- 
ple, REF and Balb/3T3 clone A31, shown in Figs. 
4 and 6, respectively. The only progressive change 
in the PA pattern that occurs as the C57B1/6 cells 
go  through  their finite, characteristic number  of 
generations in culture is that the peak of the PA 
activity  is  successively  lower  at  each  passage. 
Thus,  the  PA level of confluent  primary cells is 
136  R.U./mg  whereas  that  of confluent  fourth- 
passage cells, which will not undergo further divi- 
sions in culture, is only 52  R.U./mg. The decline 
in peak PA levels accompanies a gradual decline 
of the cell growth rate  in  the aging cultures and 
may be related to it. 
At  the  same  time  that  the  cell-associated PA 
levels are changing in growing cultures of C57B1/6 
cells, similar density-dependent changes occur in 
the amount of PA that the cells secrete. As shown 
in Fig. 8, the amount of PA secreted (recovered in 
the serum-free conditioned medium) per 106 cells 
is not  measurable when  the  cells are sparse  but 
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FmURE  7  Cell-associated  PA activity (0) as a function 
of cell density and passage number in normal  C57B1/6 
embryo  fibroblast  cultures.  Cell  counts  on  100-mm 
dishes (￿9  visual confluence (arrows), and passaging of 
the  cells to  new  plates  (double  slash  marks)  are  all 
indicated. On days of cell passaging, the samples for PA 
determination  came from confluent  plates before tryp- 
sinization. 
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FIGURE 8  Secreted  PA activity (I) collected in 10 ml 
of serum-free medium per 100-mm plate as a function of 
cell density, in cultures of normal low-passage C57B1/6 
embryo  fibroblasts. Daily cell counts  (O)  and  visual 
confluence (arrow) are also indicated. 
increases gradually to 55 R.U./106 cells per 4 h as 
the  cells become confluent. A  broad  plateau of 
active PA secretion is followed by a  gradual de- 
crease  as  the  cells  progress  into  the  stationary 
phase  of growth.  Thus,  both  the  cell-associated 
and the secreted PA levels of normal mouse em- 
bryo  cells  in  culture  vary  as  a  function of  cell 
density and reach their peak at confluence. 
Overlay fibrinolysis assays  of sparse  and con- 
fluent C57B1/6  cultures were performed to deter- 
mine whether the peak of cell-associated PA activ- 
ity resulted from a few particularly active cells in 
confluent cultures  or  from  the  development of 
moderately high PA activity in many ceils as they 
became confluent. The large, multi-focal area of 
fibrinolytic digestion  in  confluent  plasminogen- 
containing plates,  contrasted  with  the  lack  of 
plaques in similar sparse  plates, indicates that  a 
significant fraction of the cells in a given culture 
undergo the same changes in PA production and 
release as are observed grossly for the culture as a 
whole, though the cells of a given culture are not 
uniformly active (data not shown). No fibrinolytic 
plaques  are  present  in  confluent plates  lacking 
plasminogen, demonstrating that the observed ac- 
tivity is entirely plasminogen-dependent. 
To  assess  the  importance of cell death  in the 
decline of PA  activity after  cell confluence, we 
carried out vital staining experiments on cultures 
of different densities. The number of trypan blue- 
stained, presumably nonviable cells, is uniformly 
small  throughout  the  10-day  experiment,  never 
reaching even 2% of the total cell number. By the 
criterion of dye exclusion, then, stationary C57B1/ 
6 cultures do not amass dead cells, and cell death 
probably cannot account for the loss of cell-associ- 
ated PA activity after confluence. 
Cell-Associated lnhibitors 
of Fibrinolysis 
Inhibitors of fibrinolysis are  found associated 
with cell extracts from normal embryo fibroblasts 
of many species cultured in the presence of serum, 
as determined by the depression of the PA assay 
when these extracts are mixed with similar extracts 
from transformed cells (S. Rohrlich, unpublished 
results);  whether  this  inhibitory activity derives 
from the cells or from the serum in which they are 
cultured has not yet been determined. Whatever 
their origin, however, cell-associated inhibitors of 
fibrinolysis  could mask true cell-associated PA lev- 
els. We therefore attempted to use acid treatment 
(pH  2,  at  room  temperature,  for  2J/2 h,  then 
reneutralization),  which destroys the inhibitory ca- 
pacity of several serum inhibitors (11), to remove 
as much of the cell-associated inhibitory capacity 
of cell extracts as possible. Such a strategy cannot 
be used with C57B1/6 cell extracts; the mouse PA 
activity cannot be recovered from acid-treated ex- 
tracts. The PA in HEF extracts, however, is still 
recoverable after acid treatment, and the results of 
acid treatment of HEF extracts are shown in Fig. 
9.  The  difference  between  the  curve  for  acid- 
treated  extracts  and  that  for  untreated  extracts 
indicates that changes in the amount of cell-associ- 
ated acid-labile inhibitors take place, with an in- 
crease  in  such  inhibitors  after  3  days.  These 
changes in the level of cell-associated acid-labile 
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FIGURE 9  Cell-associated PA activity of normal low- 
passage HEF cells extracted and assayed without further 
treatment (I) or acid-treated at pH 2 for 21/2 h at room 
temperature,  then reneutralized before assay (O). The 
difference between the two curves represents the amount 
of cell-associated  acid-labile inhibitors of fibrinolysis  as a 
function of days in culture. Refer to Fig. 3 for growth 
CUrve. 
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changes in these cells, however, increasing as the 
PA level increases and decreasing as it decreases, 
and so they cannot account for the rise and subse- 
quent  fall  of  apparent  cell-associated  PA  as  a 
function of cell density. 
Since acid-stable protease  inhibitors (stable to 
7%  perchloric acid)  have been found in several 
tissues (9, 25, 26) and in FCS (D. Rifkin, unpub- 
lished results), the level of these inhibitors in the 
cell extracts also seemed of interest. As shown in 
Table I A, we found that protease inhibitors stable 
to 7% perchloric acid are present at similar spe- 
cific  activities in  sparse  and confluent HEF  ex- 
tracts, so that these also cannot account for the PA 
changes seen. 
Perturbations of Mouse 
PA  Production 
To determine how serum affects cell-associated 
PA levels, we performed a number of experiments 
in which serum was first  removed from the cells 
and later added back. After an initial drop in cell- 
associated PA resulting from TD washing and the 
addition  of  new  medium,  C57B1/6  cells  main- 
tained in  serum-free  medium develop increased 
cell-associated PA levels (Fig.  10).  Over a  16-h 
period, the PA level may increase as much as 20- 
fold. By 20-24 h in serum-free medium, the peak 
of PA has passed and the cell-associated PA be- 
TABLE  I 
lnhibitors of Trypsin and Plasmin Associated with 
HEF Cell Extracts 
Trypsin  Plasmin 
Protein  Trypsin  inhibi-  Plasmin  inhibi- 
Sample  assayed  inhibition  tion/tzg  inhibition  tion/.gg 
tLg 
A.' HEF sparse  28  38.92  1.39 
HEF confluent  28  44.51  1.59 
B.$ Control HEF 
Sample a  90  22.26  0.25 
Sample b  100  20.36  0.20 
17-h HEF 
Sample a  102  17.81  0.17 
Sample b  103  22.70  0.22 
4-h HEF 
Sample a  102  26.39  0.26 
Sample b  96  20.76  0.22 
% 
26.05  0.93 
44.39  1.59 
" Cells extracted with 0.1 M Tris-HCI, pH 8.1, containing 0.5% Triton X- 
100, and assayed in the trypsin and plasmin inhibitor assays after perchloric 
acid treatment  and dialysis as described in Materials and Methods. 
r HEF cells,  plated  at  1  x  10  ~ cells/100-mm  plate  in  Eagle's  minimal 
medium  supplemented  with  10%  FCS (control  HEF),  were deprived  of 
serum for  17 h (17-h HEF),  then resupplied with 10% FCS for 4 h (4-h 
HEF). Duplicate samples were scraped, extracted, and assayed in the trypsin 
inhibitor assay at each time, giving the values recorded here. 
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FIGURE 10  Variations in cell-associated  PA activity re- 
lated to the presence or absence of serum, as a function 
of the plating density of C57B1/6 cells on 100-ram  dishes. 
Ceils seeded at 5 x  105 (Q), 1 x  106 (A), 5 x  106 (O), 
and 1 x  107 (A) cells/plate in medium containing 10% 
FCS were washed with TD the next day and placed in 10 
ml/plate  of  serum-free medium.  Sample plates were 
scraped just before the change to serum-free medium 
(solid arrow), after 20 h in serum-free medium, and at 
the indicated times after the re-addition of medium with 
10% FCS (empty arrow). 
2  3  4-4 
gins to decline again (not illustrated), The timing 
of  this  PA  rise  and  decline can  vary  by  a  few 
hours. If medium containing serum (10% FCS) is 
added to the cells at any point, the cell-associated 
PA drops immediately and remains at a very low 
level  or  declines further  for  a  few  hours;  only 
gradually over the course of the next 24 h does it 
approach its original baseline level. Fig. 10 shows 
this pattern of PA increase, decrease, and return 
to baseline level for cells plated at four different 
densities. As illustrated, the cells plated at differ- 
ent densities start with relative PA levels charac- 
teristic of their seeding densities, and they regain 
this same relative pattern at the end of the experi- 
ment. The actual values of the initial PA levels for 
a  given plating density, however,  are  somewhat 
variable, and are not quantitatively  identical to the 
PA levels found for cells at corresponding densi- 
ties in long-term culture, either in these C57B1/6 
experiments or in those  with HEF cells (see be- 
low). We cannot explain this observed initial vari- 
ability. Not illustrated are qualitatively similar re- 
sults  from  an  equivalent experiment performed 
with HEF cells. In this experiment, the control PA 
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100-ram plate, was  600 R.U./mg, rose to 2,975 
R.U./mg after  17  h  in serum-free medium, and 
fell  again to  1,175  R.U./mg after 4  h  in serum- 
supplemented medium. 
Analysis of the mouse cells' response to serum- 
free  medium  (Fig.  11)  shows  that  the  induced 
increase  in  PA  activity requires  that  RNA  and 
protein  synthesis be  sustained,  if not  newly in- 
duced,  and  that  it  is  energy-dependent. No  in- 
crease in cell-associated PA is seen in the presence 
of 5/.tg/ml cycloheximide or 4/,tg/ml actinomycin 
D  (although the depression of PA production in 
response to this drug is delayed), nor in the pres- 
ence of a mixture of 1 mM sodium azide and 10 
mM  sodium  fluoride  which  together  block  80- 
90%  of the cells' aerobic and anaerobic respira- 
tion (27). By contrast, neither 10/xg/ml cytosine 
arabinoside, which inhibits DNA synthesis, nor 2 
x  10 -~ M dibucaine or 10/zg/ml colchicine, both 
of which  have been reported  to  affect  secretion 
and cytoskeletal integrity (13, 20, 24, 30), has any 
effect. 
The PA increase in the absence of serum proba- 
bly results from increased PA  production rather 
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FmuI~E 11  The  effect of drugs on  the  rise in  cell- 
associated PA in the absence of serum. C57B!/6 cells 
were seeded on  100-mm plates at 2  x  10  ~ cells/plate. 
The next day, at 0 h, sample plates were scraped and the 
other plates were washed with TD and put into 10 ml/ 
plate of serum-free medium without drugs (0), or with 
10/zg/ml cytosine arabinoside (O), 4/zg/ml actinomycin 
D (A), 5 p.g/ml cycloheximide  (A), 10/~g/ml colchicine 
(ll), 2 ￿  10  -5 M dibucaine (D), or 1 mM sodium azide 
and 10 mM sodium fluoride (￿  Sample plates were 
scraped at the indicated times. 
than  from  adsorption  of secreted  PA.  BSA  in- 
cluded in the serum-free medium does not reduce 
the  cell-associated  PA;  the  cell-associated  PA 
level is as high or higher in the presence of 0.1% 
BSA than in its absence (data not shown). Still, 
adsorption of secreted PA could be specific,  and 
cannot  be  rigorously  ruled  out  at  present.  At- 
tempts  to  remove  all  ceil-adsorbed  material  by 
trypsinization of the cells before extraction failed, 
since, even after extensive washing, trace amounts 
of residual trypsin interfered with the fibrinolytic 
assay. Direct measurements of the ability of these 
extracts to activate plasminogen in the presence of 
trasylol (an inhibitor of plasmin and trypsin, but 
not of PA), as determined by the appearance of 
the plasmin heavy and light chains on gels under 
reducing conditions, also could not be done; the 
assay  was  not  sensitive enough  to  measure  the 
small amounts of activator involved, even when 
t25I-plasminogen  with a specific activity as high as 
1.3 p,  Ci/p,g  was used. 
Finally, as shown in Table I B, protease inhibi- 
tors associated with control HEF cell extracts are 
present with nearly the same specific  activities in 
the  extracts  from  the  serum-deprived cells  and 
from  the  cells  after  they  have  been  in  serum- 
supplemented medium again for 4 h and therefore 
cannot account for  the  apparent  serum-induced 
PA changes observed. 
Thus the  increase in cell-associated PA  levels 
induced by the removal of serum from C57B1/6 or 
HEF cells is energy-dependent, requires RNA and 
protein  synthesis,  and  presumably  results  from 
increased  PA  production, rather  than  from  PA 
accumulation or  adsorption  or  from  changes  in 
cell-associated protease  inhibitors. Furthermore, 
it cannot be accounted for by a shift from secretion 
of PA to intracellular accumulation of PA, since 
secretion is active and measurable in the absence 
of serum. Fig. 8  shows PA secreted by cells  de- 
prived of serum for 4 h. By 16 h (not shown) the 
amount of secreted PA has increased on all days 
except  days 8-10, where  it  had already reached 
saturation levels in the medium by 4 h. Thus, PA 
levels in the  serum-free medium increase rather 
than diminish with time, indicating that removal of 
serum does not block PA secretion. 
The  decrease  of  PA  upon  serum-readdition 
seems to represent repression of PA. As discussed 
above  and  shown  in  Table  I  B,  cell-associated 
protease  inhibitors  are  not  important  in  the 
change. The  use  of medium supplemented with 
10,  1,  or  0.1%  of either  native or  acid-treated 
S.  T.  ROHRLlCH AND  D.  B.  RIFK~ Plasminogen  Activator in Normal Cells  39 FCS (Fig. 12) to replace serum-free medium after 
16 h shows that acid-treated serum is just as effec- 
tive as native serum in bringing about the deinduc- 
tion within 4 h after serum readdition, although it 
is depleted of about 90% of its protease inhibitors. 
We  do  not understand the  transient increase in 
apparent  PA  immediately after  the  addition  of 
acid-treated serum. 
As shown in Fig. 12, the final depression of PA 
activity (after 4  h) is less in cells with the  1 and 
0.1%  serum  supplements as  compared  to  cells 
with  the  10%  serum  supplement, for  both  the 
native and the acid-treated sera. Thus, the extent 
of PA depression is dependent upon the concen- 
tration  of  serum  added  back,  but  not  upon  its 
content of protease inhibitors. These results sug- 
gest the presence in serum of some other regula- 
tory effectors, such as hormones, which modulate 
cellular PA synthesis. 
DISCUSSION 
Our results show that the cell-associated PA activ- 
ity  of low-passage  normal embryo fibroblasts is 
not uniformly low throughout their life in culture. 
On  the  contrary, fibroblasts from  a  number of 
different species develop variously elevated levels 
of intracellular PA  as  they  approach  and attain 
confluence, and gradually lose this activity as they 
pass confluence. In all cases,  however, even the 
r 
 6ooI 
n-- 
400 
ot,,   ! 
4  12  20 
0 
IIIil 
4  12  20 
Time (h) 
FIGURE 12  Serum  effect on cells deprived of serum for 
16 h. C57B1/6 cells plated at 2  x  l0  s cells/plate were 
TD-washed the  next day and put  into  10 ml/plate of 
serum-free medium. Sample plates were scraped before 
the addition of serum-free medium (solid arrow), after 
16 h in the absence of serum (empty arrow), and at 15 
min and 4 h after a medium change to new serum-free 
medium (O), medium with 10% FCS (&), 1% FCS (￿9 
or 0.1%  FCS (A),  or medium with 10%  acid-treated 
FCS  (1),  1%  acid-treated  FCS  (O),  or  0.1%  acid- 
treated FCS (￿ 
peak  PA  activities of normal low-passage fibro- 
blasts remain well below those of their virally or 
spontaneously transformed counterparts. 
A  different situation prevails for the two Balb/ 
3T3 clones studied. Although the Balb/3T3 line is 
generally regarded as "normal", the cells of both 
clones  tested  attain  much  higher  peaks  of  PA 
activity at confluence than any of the low-passage 
embryonic mouse cells tested, and they maintain 
this peak activity indefinitely beyond confluence. 
In this regard, our findings with Balb/3T3 do not 
agree with those reported by Chou et al. (5) who 
found that the PA of Swiss 3T3 declined after the 
cells  reached  confluence.  Furthermore,  fresh 
MSV transformants of the Balb/3T3 clones have 
lower  cell-associated  PA  activities than  the  un- 
transformed cells. We cannot provide an explana- 
tion for these observations, but we think that this 
anomalous behavior of cell lines, as compared to 
low-passage cells, is worth noting. Differences in 
the behavior of cell lines and primary cultures with 
respect to PA production have been investigated 
extensively by Rifkin and Pollack (23), and were 
also noted by Mott et al. (15) and by Jones et al. 
(8). 
Our  main interest  has  been  in  analyzing the 
regulation of PA in normal low-passage embryo 
fibroblasts. We have considered the  interplay of 
cellular metabolism, activator production and se- 
cretion, activator adsorption, and cell-produced or 
adsorbed inhibitors of fibrinolysis. The increase of 
PA levels in cells maintained in serum appears to 
represent changes in PA synthesis. It requires ac- 
tive cell metabolism, and, so, is directly influenced 
by the level of serum supplementation of the cul- 
ture medium and by the growth rate of the culture. 
Other possible explanations for the PA increase, 
such as changes in intracellular PA storage, cell- 
surface  bound secreted  PA,  and  cell-associated 
inhibitors of fibrinolysis, were also considered. At 
least in the  C57B1/6  cells, secreted  PA patterns 
are similar to cell-associated PA patterns over a 
10-day period, an observation which agrees with 
previous findings that PA is rapidly secreted from 
many cells  as  it  is  made  (21).  It  is,  therefore, 
unlikely that the observed differences in cell-asso- 
ciated PA levels can be attributed to changes in 
PA  storage  patterns in the  cells.  They  are  also 
unlikely to result simply from an accumulation of 
secreted  material  adhering  to  the  cell  surface. 
Since the cell-associated PA level falls during the 
cells'  stationary  phase,  some  mechanism  other 
than trypsinization and passaging would have to 
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confluence,  if such  adsorption  occurred.  PA  ad- 
sorption cannot be rigorously ruled out at present, 
however, because the appropriate experiments are 
prevented by technical difficulties. Changes in the 
levels  of  cell-associated  inhibitors  of fibrinolysis 
also cannot  account  for the observed  changes  in 
cell-associated PA levels of growing cells. 
In cells deprived of serum, PA synthesis appears 
to go unchecked or even be stimulated for 16-20 
h. The observed PA increase is energy-dependent 
and requires ongoing RNA and protein synthesis; 
it is not clear whether an increased level of synthe- 
sis  must  be  induced.  The  increase  in  cell-associ- 
ated  PA  in  serum-deprived  cells  results  from 
changes  in  PA  production  rather  than  from 
changes in PA secretion, since secreted PA levels 
increase over the same  16-h period during which 
the  cell-associated  levels  increase.  Over-produc- 
tion of PA stops by 20-24 h, and a gradual decline 
in PA occurs at this time. If serum is resupplied to 
the cells at 20 h, the apparent PA level of the cells 
falls precipitously to zero, and only over the next 
24  h  do the  cells begin  to recover their baseline 
PA levels. The extent of the decline in PA is de- 
pendent  upon  the  concentration  of serum  added 
but  not  upon  its  content  of  acid-labile  protease 
inhibitors.  This  would  suggest  that  some  as  yet 
unidentified acid-stable serum component exerts a 
negative regulatory effect on PA production. 
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